BREAKING NEWS
Coronavirus
Thailand Coronavirus News is a section dedicated to the new coronavirus that is causing an epidemic in China and fast spreading globally. The strain of coronavirus called Covid-19 or also commonly called the Wuhan coronavirus is genetically more potent and faster spreading than the SARS coronavirus. Currently teams are working to develop a new vaccine for this new coronavirus while other teams are...
Source: V483G Mutation  Sep 21, 2020  2 years ago
V483G Mutation: Researchers And health Officials are warning that  that a mutant strain of the SARS-CoV-2 coronavirus, the V483G strain is fast making appearances in various countries including India, Brazil, The Middles-East, UK and even in the United States.   According to genomic experts and immunologist, the V483 strain is resistant to the neutralizing properties of antibodies and ...
Source: Post-COVID Myocarditis  Sep 21, 2020  2 years ago
Post-COVID Myocarditis: As a result of alarming data showing that a majority of recovered COVID-19 patients have some sort of heart tissue damage after being infected with the SARS-CoV-2 coronavirus irrespective of whatever the conditions they had endured ie from mild, moderate , severe or asymptomatic, there is a huge rush by many concerned to go for heart screenings. https://www.thailandmedical....
Source: America Coronavirus   Sep 21, 2020  2 years ago
America Coronavirus: American official COVID-19 infection rates hits 6.81 million and 200,014 Americans have died from the COVID-19 so far though actual figures are expected to be much higher. Americans are expected to have a great time for the rest of the year and also an interesting year end festive season never experienced in its history starting from next month’s Halloween as many more a...
Source: COVID-19 Latest  Sep 21, 2020  2 years ago
COVID-19 Latest: A new study by French researchers from Aix-Marseille University, IHU-Méditerranée Infection, Institut Paoli Calmettes and Laboratoire d’Immunologie-Marseille, including the controversial  French physician and microbiologist Professor Dr Didier Raoult have discovered that the SARS-CoV-2 coronavirus basically causes immunoparalysis in the human hos...
Source: COVID-19 Scams  Sep 21, 2020  2 years ago
COVID-19 Scams: Of all the stupidity and craziness which not many people are questioning (the intelligence levels in America has sunk to its lowest!) is the new American standard for drug approvals set by the US FDA under the Trump administration in which as long you can demonstrate somehow by whatever means that a drug is able to shorten hospitalization stays, Voila! You get approved and you can ...
Source: COVID-19 News  Sep 21, 2020  2 years ago
COVID-19-News: Initial hypothesis that the it was the cytokine storms as a result of SARS-Cov-2 infections that were destroying various organ tissues including the heart, kidneys, intestines and even brain tissues are now being replaced with the stark fact it is actually the SARS-CoV-2 coronavirus itself that is causing these issues and in some cases it might be also compounded by the inflammatory...
Source: Drugs-COVID-19  Sep 21, 2020  2 years ago
Drugs-COVID-19: Spanish researchers from the Department of Cell Biology at the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have identified 4-Phenylbutiric acid or 4-PBA as a possible drug candidate to treat the various inflammatory and immune issues resulting from the SARS-CoV-2 coronavirus infection that causes COVID-19 disease.   The s...
Source: Disinfectants-COVID-19  Sep 20, 2020  2 years ago
Disinfectants-COVID-19: To curb the problem of current COVID-19 disinfectants taking time to sanitize surfaces and the impracticability of using them on high-contact areas such as door handles, elevators, and bannisters due to ‘wearing-off' effects, researchers from the University of Central Florida (UCF) are co-developing a new, rapid-acting, long-lasting disinfectant spray that instant...
Source: COVID-19 Research  Sep 20, 2020  2 years ago
COVID-19 Research: Japanese researchers from the Kyoto Prefectural University of Medicine and Osaka University have engineered to create soluble ACE2 (sACE2) in human cells that have enhanced affinity to receptor-binding domain (RBD) of the SARS-CoV-2 thus serving as decoy while also neutralizing the novel coronavirus.   The research findings were published on a preprint serve and are curre...
Source: Therapeutic Herbal Teas  Sep 19, 2020  2 years ago
As a result of overwhelming response and also a new promotional program with postal authorities and also with certain well-wishers who wish to make our specially blended therapeutic herbal teas more accessible to  as many Americans as possible to better equipped themselves with the coming cooler season and the impending COVID-19 second wave, Thailand Medical News announces that we now offer a...
Source: Mpro Inhibitors  Sep 19, 2020  2 years ago
Mpro Inhibitors: A new study led by researchers from the university of Arizona with additional support from the University of Athens shows that all previous studies indicating that Mpro Inhibitors Such As Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, And Shikonin have antiviral properties against the SARS-CoV-2 coronavirus are invalidated as the new research shows that these Mpro inhibitors ar...
Source: Ketogenic Diet And COVID-19  Sep 19, 2020  2 years ago
Ketogenic Diet And COVID-19: Researchers in a new study led by Yale School of Medicine but also involving scientist from New York University Langone Health and Washington University School of Medicine, advocate a ketogenic diet (A diet in high fat, low carbohydrate) for elderly COVID-19 patients and even those not infected yet it is capable of mitigating clinical outcomes of COVID-19 in this vulne...
Source: Coronavirus Breakthrough  Sep 19, 2020  2 years ago
Coronavirus Breakthrough:  Researchers from University of Kentucky College of Medicine in a new study have discovered that as a result localized inflammation in the lungs, a deficiency of the anticoagulant protein S results that leads to thrombosis in COVID-19 patients. The localized inflammation also leads to elevated levels of tissue factor, a protein found in blood that initiates the clott...
Source: ACE2  Sep 19, 2020  2 years ago
A new study by experts from the Department of Biochemistry of the University of Wisconsin-Madison reveals that the genetic variants of human angiotensin 2 or ACE2 receptors can have altered recognition by SARS-CoV-2 coronavirus, the causative agent COVID-19) pandemic.   Comprehending how human ACE2 genetic variants differ in their recognition by SARS-CoV-2 can have a major impact in le...
Source: Strokes And COVID-19  Sep 19, 2020  2 years ago
Strokes And COVID-19: According to a new study from University of Alabama at Birmingham led by Dr Chen Lin, M.D., an assistant professor in the Department of Neurology, stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19.   The new study finding co...
Source: Fatigue  Sep 18, 2020  2 years ago
Fatigue: Study findings from a new research by Dr Liam Townsend, St James's Hospital and Trinity Translational Medicine Institute, Trinity College, Dublin, Ireland, and colleagues showed that that persistent fatigue occurs in more than half of patients recovered from COVID-19, regardless of the seriousness of their infection.   The study findings were presented online at the recent ESCM...
Source: ACE2  Sep 18, 2020  2 years ago
ACE2: Eight months into the COVID-19 pandemic which started in Wuhan, China and spread to the rest of the world (thanks due to the incompetency of a certainHealth Organization) with disastrous effects both on the lives and economic aspects of billions of people globally with the exception of China which seems to have escaped the disastrous effects mysteriously, global researchers are now realizing...
Source: Coronavirus Supplements  Sep 18, 2020  2 years ago
Coronavirus Supplements: Researchers from the University of Nebraska Medical Center and Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring have demonstrated in vitro studies that bromelain extracted from pineapples is able to inhibit the SARS-CoV-2 coronavirus in Vero E6 cells via a  multitude of ways.   The study findings are published on a preprint server and are...
Source: COVID-19 Antibodies  Sep 18, 2020  2 years ago
COVID-19 Antibodies: A new research by scientists from the Rockefeller University and the University of North Carolina-Chapel Hill shows that a combination of neutralizing antibodies with intact Fc effector function can effectively reduce the viral load and prevent infection.   The study results were published on a preprint server and are pending peer review. https://www.biorxiv.o...
Source: COVID-19 Research  Sep 18, 2020  2 years ago
COVID-19 Research: Contrary to a fallacy that has been installed in many through fake misinformation disseminated by so called medical ‘experts’ and health organizations during the early stages of the COVID-19 pandemic that only the elderly are susceptible to COVID-19 and that younger adults are most likely to withstand the infections and only endure mild symptoms, new data is showing ...
Source: Coronavirus Latest  Sep 17, 2020  2 years ago
Coronavirus Latest: Researchers from the Crick's Structural Biology of Disease Processes Laboratory at the Francis Crick Institute-London have found that the spike protein on the surface of the SARS-CoV-2 coronavirus can adopt at least ten distinct structural states, when in contact with the human virus receptor ACE2. The structural states of the SARS-CoV-2 spike protein, binding to the huma...
Source: Coronavirus Antivirals  Sep 17, 2020  2 years ago
Coronavirus Antivirals: Researchers from University of Chinese Academy of Sciences, Shanghai-China have identified the antibiotic Ceftazidime as possible antiviral candidate to inhibit SARS-CoV-2 coronavirus and treat the COVID-19 disease. The research findings were published on a preprint server and have yet to be peer reviewed. https://www.biorxiv.org/content/10.1101/2020.09.14.295956v1   ...
Source: COVID-19 Immunotherapy  Sep 17, 2020  2 years ago
COVID-19 Immunotherapy: Researchers from Corvus Pharmaceuticals Inc-California, Temple University-Philadelphia and Icahn School of Medicine at Mount Sinai-New York in a phase 1 clinical trial have demonstrated that using a Inhibitor Of CD73 Enzymatic Activity called CPI-006, the researchers were able to induce the effective B Cell and Humoral response to SARS-CoV-2 infection in COVID-19 patients e...
Source: India News  Sep 17, 2020  2 years ago
India News: Researchers and scientists from the Virology Division of India’s Defense Research and Development Establishment has discovered  that there are multiple viral introduction events in central India, and SARS-CoV-2 coronavirus with D614G mutation is the prevalently circulating strain. Even more concerning are new mutation variants emerging in India.   The study ...
Source: COVID-19 Meds  Sep 17, 2020  2 years ago
COVID-19 Meds: A new vitro study led by Austrian researchers from the University of Vienna has demonstrated that the nasal antihistamine Azelastine was able to inhibit SARS-CoV-2 infections in assays using reconstituted human nasal tissue and Vero E6 monkey kidney epithelial cells. The study team says that Azalastine is a prospective drug candidate that could be used to reduce viral transmission i...
Source: COVID-19 Drugs  Sep 17, 2020  2 years ago
COVID-19 Drugs: Azithromycin, a commonly-prescribed antibiotic that also is being investigated as a potential treatment for COVID-19 according to a new study by researchers from the University of Illinois Chicago, by itself is not associated with an increase in cardiac events; however, if taken with certain other drugs that affect the electrical functioning of the heart, then cardiac events increa...
Source: COVID-19 T Cells  Sep 17, 2020  2 years ago
COVID-19 T Cells: Since the debut of the SARS-CoV-2, scientist have been trying to figure out if the immune system actually  helps or is making things more worse in the case of the COVID-19 disease but a new study by researchers from  La Jolla Institute for Immunology- California  clearly argues in favor of the immune system.   By examining all three branches of adaptive immu...
Source: U.S. Medical News  Sep 16, 2020  2 years ago
U.S. Medical News: It simply frightening what’s happening in America at the moment. Literally every agency from the FDA, NIH, CDC to the State Health Departments is being manipulated by the White House and supported by certain media and social media platforms including Twitter (it might come as a shock to many but Twitter is actually pro-Trump despite the farce about labeling some of his twe...
Source: COVID-19 Research  Sep 16, 2020  2 years ago
COVID-19 Research: Scientists from the University of California San Diego School of Medicine have found that the SARS-CoV-2 coronavirus needs a carbohydrate compound called heparin sulfate which is also found on lung cell surfaces and acts as a co-receptor for viral entry as it facilitates binding to te ACE2 receptors.   The study team said that SARS-CoV-2 spike protein interacts with both ...
Source: World COVID-19 News  Sep 16, 2020  2 years ago
World COVID-19 News: As India's total of coronavirus infections passed 5 million on Wednesday, and cases are still continuing to soar, its public healthcare system is on the verge of a collapse as they are no longer hospital beds in many states and already there is a growing shortage of medical supplies and even oxygen for medical use.   India has has added more than 1 million cases of ...
Source: COVID-19 Immunity  Sep 16, 2020  2 years ago
COVID-19 Immunity: A new European study by researchers from University of Amsterdam-Netherland, INGENASA Institute-Spain and University of Antwerp-Belgium have found that immunity to four existing seasonal coronaviruses are short-lasting and that the duration of protective immunity against SARS-CoV-2 may be also short-lived.   The study findings are from a case study of ten healthy subjects...
Source: Coronavirus News  Sep 16, 2020  2 years ago
Coronavirus News: A new study by Chinese researchers from Department of Environmental Science and Engineering, Xi'an Jiaotong University-Xi'an,has found that microfiber pillows are excellent reservoirs of the SARS-CoV-2 coronavirus. What is alarming is that not are these type of pillows used extensively in home stings globally but more so in hotels, cinemas, trains, airplanes, ships and co...
Source: Flu Pandemic  Sep 16, 2020  2 years ago
Flu Pandemic: According to new reports by American scientist and even army intelligence, China is facing a new outbreak of Swine Flu called G4 EA H1N1 that it trying hard to control and at the same time conceal from the rest of the world. Report of the new viral swine flu strain first emerged in media in June and July but was played down as usual by WHO and also The Chinese authorities.   S...
Source: Flu-COVID-19  Sep 15, 2020  2 years ago
Flu-COVID-19: German researchers from the Max Planck Institute for Infection Biology in Berlin and French scientists from the Institut Pasteur in Paris used a mathematical model to study the first months of the COVID-19 pandemic in Europe. They found that the decrease of COVID-19 cases in spring was not only related to countermeasures but more importantly due to the end of the flu season. Influenz...
Source: Coronavirus Updates  Sep 15, 2020  2 years ago
Coronavirus Updates: UK Facing Test Kit Shortages British healthcare services are being jeopardized by lack of access to COVID-19 testing, hospital bosses in England warned on Tuesday. NHS Providers, which represents the heads of hospital trusts in the state-run National Health Service, said there were "current capacity problems with the testing regime". Its chief executive Chris Hopso...
Source: Coronavirus News  Sep 15, 2020  2 years ago
Coronavirus News: Middle-east researchers from the American University of Beirut-Lebanon and Qatar University-Doha say that the SARS-CoV-2 coronavirus that caused the COVID-019 disease will ultimately become a seasonal virus just like influenza but not just yet. It only till a global herd immunity is achieved that will this happen.   Their review was published in the journal: Frontiers in P...
Source: COVID-19 Warning  Sep 15, 2020  2 years ago
COVID-19 Warning: Humanity has sunk to its lowest especially in Western societies like those in America where as a result differences of opinion and thoughts, groups of malicious individuals are willing to cause harm to others without thinking of the consequences. A Biohacker Kit Sold online for making homemade biological weapons with the SARS-CoV-2 coronavirus Credit: Thailand Medical News. &nb...
Source: COVID-19 Vaccines  Sep 15, 2020  2 years ago
COVID-19 Vaccines: As there is growing public concern especially from the scientific community about the recent adverse reactions from AstraZenaca’s COVID-19 vaccine trial, the U.S.FDA is considering whether to follow British regulators in resuming a COVID-19 vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched a...
Source: COVID-19 Latest  Sep 15, 2020  2 years ago
COVID-19 Latest: Scientist from the Aix-Marseille University-France and Méditerranée Infection Foundation (IHU)- France  in a new controversial study shows that the time of the day can affect infection with the SARS-CoV-2, as well as guide subsequent host immune response implying that circadian rhythm may well be a novel target for managing viral progression.   The study ...
Source: COVID-19 News  Sep 15, 2020  2 years ago
COVID-19 News: An international study lead by researchers from 25 institutions in Europe, America and Australia have found that smoking increases ACE2 receptors expression while inhaling corticosteroids has the opposite effect of suppressing the expression of these virus binding receptors.   The study findings in brief found that genes encoding viral receptors and activating protease are in...
Source: COVID-19 Second Wave Preparations  Sep 15, 2020  2 years ago
COVID-19 Second Wave Preparations: Researchers from John Hopkins University School of Medicine in a new study have found that it is useful for a pulse oximeter to be used at home to monitor COVID-19 patients.   The study was published on a preprint server and has yet to have been peer-reviewed. https://www.medrxiv.org/content/10.1101/2020.09.01.20184937v1   Accordingly a pulse oximeter...
Source: COVID-19 Drugs  Sep 14, 2020  2 years ago
COVID-19 Drugs: Researchers from the University of Pittsburgh School of Medicine claim to have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 coronavirus.   The research findings were published in the journal: Cell https://www.cell.com/cell/pdf/S0092-8674(20)31148-X.pdf?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%...
Source: Coronavirus Research  Sep 14, 2020  2 years ago
Coronavirus Research: Scientist from Yale University School Of Medicine, St. Jude Children's Research Hospital-Memphis, National Institutes of Health-Bethesda, Columbia University and  Montreal University-Canada using an imaging platform that utilizes single-molecule Förster resonance energy transfer (FRET) have discovered that the spike proteins of the SARS-CoV-2 coronavirus has 4 d...
Source: News-Coronavirus  Sep 14, 2020  2 years ago
WHO (World Health Organization) reported 307,930 new cases worldwide on Sunday, the highest daily figure in its database since the beginning of the pandemic.   The surge has sparked concern in Europe, where Austrian Chancellor Sebastian Kurz warned that his country was facing "the beginning of the second wave".   At the same time the Czech Republic has also faced a surge, wit...
Source: COVID-19 Vaccine  Sep 14, 2020  2 years ago
COVID-19 Vaccine : The AIDS Healthcare Foundation (AHF), the largest global AIDS organization, today (Monday,14th September)  sharply criticized pharmaceutical and biotech  companies working on COVID-19 vaccines over a near total lack of transparency on the companies’ respective trials, including setbacks with AstraZeneca’s vaccine trial that briefly forced its suspensio...
Source: Coronavirus News  Sep 14, 2020  2 years ago
Coronavirus News: Researchers from the Department of Hydrobiology at the Institute of DACBiol at the Universidad Juárez Autónoma de Tabasco-Mexico are warning that careful attention and monitoring needs to be paid to the aquatic life forms and water life as they could be potential impacts from the current COVID-19 pandemic. The researchers expressed their concerns and study findings...
Source: Vaccines-COVID-19  Sep 14, 2020  2 years ago
Vaccines-COVID-19: Indian researchers from vaccine developer Bharat Biotech International Ltd in collaboration with researchers National Institute of Virology-Indian Council of Medical Research have conducted a preclinical study demonstrating the safety and efficacy of a new candidate vaccine against the SARS-CoV-2 coronavirus, the pathogen that causes the COVID-19 disease.   The ...
Source: COVID-19 Mask  Sep 14, 2020  2 years ago
COVID-19 Mask: A study and development team from the City University of Hong Kong (CityU) has successfully produced graphene masks with an anti-bacterial efficiency of 80%, which can be enhanced to almost 100% with exposure to sunlight for around 10 minutes. Initial tests also showed very promising results in the deactivation of two species of coronaviruses. The graphene masks are easily...
Source: Latest COVID-19  Sep 13, 2020  2 years ago
Latest COVID-19 studies by researchers from the Regenerative Neurorehabilitation Laboratory (The Shirley Ryan AbilityLab) at Northwestern University Feinberg School of Medicine- Chicago have shown that proning (the technique of placing a patient in a face down position to ease breathing and reduce mortality rates) of severely ill COVID-19 patients on ventilators can cause permanent nerve...
Source: U.S. Coronavirus News  Sep 13, 2020  2 years ago
U.S. Coronavirus News: The U.S. Centers for Disease Control and Prevention said that there have been 792 confirmed cases of a rare condition in children that is linked to COVID-19 in the United States and warns that there are lots more of suspected cases being investigated and that these figures are rising.   The U.S. CDC  added that multisystem inflammatory syndrome in children (MIS-C...
Source:ACE-i And ARBs-COVID-19   Sep 13, 2020  2 years ago
ACE-i And ARBs-COVID-19: According to latest research findings presented at the virtual American Heart Association’s Hypertension 2020 Scientific Sessions that was held Sept. 10-13, 2020, reducing or eliminating high blood pressure medications if blood pressure becomes hypotensive, falling below 120/70 mm Hg, could prevent acute kidney injury (AKI) and death in COVID-19 patients. ...
Source: COVID-19 Breakthrough  Sep 13, 2020  2 years ago
COVID-19 Breakthrough: Clinical-stage biopharmaceutical company Senhwa Biosciences that is based in Taiwan with offices in San Diego has announced that its investigational drug, Silmitasertib has demonstrated remarkable effectiveness after the first patient with severe COVID-19 demonstrated remarkable recovery after using the drug. Senhwa Biosciences is a company focused on next generation DNA Da...
Source: Coronavirus News  Sep 13, 2020  2 years ago
Coronavirus News: There are unproven speculations by medical experts and scientific researchers circulating around about a particular South-East Asian country where it is estimated that about 4% of its population of locals might have already contracted the ‘milder’ strains of the SARS-CoV-2 coronavirus but almost 96 percent of these infected locals are asymptomatic while the rest might...
Source: Vaccines-COVID-19  Sep 13, 2020  2 years ago
Vaccines-COVID-19: The world’s oral recombinant adenoviral mucosal COVID-19 vaccine by Vaxart, Inc, a California based biotechnology company that is administered by tablet rather than by injection, has demonstrated positive results in a inducing potent systemic and mucosal immune responses in preclinical studies.   The study findings were published on a preprint server and are current...
Source: COVID-19 Treatments  Sep 12, 2020  2 years ago
COVID-19 Treatments: Researchers from Mississippi have in a new study found that utilizing both the antihistamines Cetirizine and Famotidine appears to reduce pulmonary symptoms and may have other benefits in patients with COVID-19. The study findings were published in the journal:  Pulmonary Pharmacology & Therapeutics https://www.sciencedirect.com/science/article/pii/S1094553920301462?...

MOST READ

Aug 13, 2020  2 years ago
Source: Supplements For COVID-19
Feb 05, 2020  3 years ago
Source : Thailand Medical news

Interesting Reads

Source: COVID-19 Convalescent Plasma and Hyperimmune Plasma Or H-Ig Therapies
Jun 15, 2020  2 years ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  2 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  2 years ago
Source: COVID-19 Long-Term Health Implications
Jun 13, 2020  2 years ago
Source: COVID-19, Influenza and Next Wave
Jun 10, 2020  2 years ago
Source: Myocardial Injury
Jun 09, 2020  2 years ago
Source: COVID-19 News
May 21, 2020  2 years ago
Source: Covid-19 Treatments And Drugs News
Mar 20, 2020  2 years ago
Source: SARS-Cov-2 Coronavirus Research
Mar 08, 2020  2 years ago
Source : Thailand Medical News
Feb 11, 2020  3 years ago